06-12
The 2023 National Medical Device Supervision and Management Work Conference was held in Beijing
On January 16, the 2023 National Medical Device Supervision and Management Work Conference was held in Beijing. Xu Jinghe, member of the Party Group and deputy Director of the State Medical Products Administration, attended the meeting and made a speech.
06-12
Medical device production supervision platform cross-regional commissioned production inspection and other new functions of the online training will be successfully held
06-12
Information related to the filing of medical device licenses by province (as of December 31, 2022)
In order to further meet the needs of the public to inquire medical device regulatory information, strengthen social supervision and social co-governance, The State Food and Drug Administration has summarized the registration and filing of medical device products, the licensing of medical device manufacturers, the licensing of medical device distributors, the filing of medical device network sales, and the filing information of third-party platforms for medical device network trading services within the validity period of the provinces (autonomous regions and municipalities directly under the Central Government), which is published on a monthly basis.
06-12
China's domestic extracorporeal membrane oxygenation (ECMO) products have been approved for market
According to the needs of epidemic prevention and control work, in order to ensure the treatment needs of severe patients with novel coronavirus pneumonia, on January 4, 2023, the State Food and Drug Administration reviewed and approved the registration application of Shenzhen Hanno Medical Technology Co., Ltd. for external cardiopulmonary support auxiliary equipment and disposable membrane oxygenator kits, which are used together. For adults with acute respiratory failure or acute cardiopulmonary failure who are difficult to control with other treatments and are at a foreseeable risk of continued deterioration or death.
06-12
Patient monitor approved for market
Recently, the State Drug Administration reviewed and approved the registration application of the "patient monitor" innovative product produced by Shenzhen Koman Medical Equipment Co., LTD.
06-12
In order to implement the spirit of the new medical reform, build an information system that meets the needs of health reform and development, and improve the level of health services and management, the Ministry of Health issued document No. 38 in 2012, which put forward clear requirements for the overall framework, basic principles and work objectives of the information construction work of various hospitals across the country. However, in view of the current situation of hospital informatization construction in China, the medical strategy team, after in-depth analysis, believes that hospital leaders have sunk cost awareness in informatization reconstruction.
06-12
Guizhou Tuoxin Medical Equipment Co., Ltd. was established in 2015, with a registered capital of 1.08 million. It is a professional enterprise engaged in medical devices. The company has been issued the "Medical Device Business License" by Zunyi Municipal Food and Drug Administration. Its business scope includes: second class ECG diagnostic instruments, non-invasive monitoring instruments, respiratory function and gas analysis devices, clinical analysis instruments, etc. Three kinds of color ultrasonic imaging equipment, anesthetic breathing equipment, disposable sterile syringe, disposable infusion set, CT equipment, etc.
06-12
The medical equipment surplus continued to shrink and the growth rate remained at 10%
Imports: Rehabilitation supplies are growing rapidly from January to September, China imported medical devices from 93 countries and regions. From the regional point of view, Europe is China's medical device import market, imports of 4.29 billion US dollars, an increase of 26.52%, the proportion of 39.42%; North America was the second largest market, with imports of 3.548 billion US dollars, an increase of 20.85%, accounting for 32.59%; Asia ranked third, with imports of 2.781 billion US dollars, an increase of 12.05%, accounting for 25.55%, and the proportion of the three continents reached 97.56%.
06-12
Recent industry and company information review 1, low-cost drug catalog is about to be introduced, some traditional Chinese medicine varieties to obtain a new life It is reported that in the relevant draft documents issued by the National Development and Reform Commission to the provinces, there are 890 varieties of dosage forms included in the list of low-cost drugs, for these varieties, the National Development and Reform Commission plans to cancel the original maximum retail price formulated by the government. Instead, it is limited to the daily use cost (i.e., less than 3 yuan for chemical drugs and less than 5 yuan for proprietary Chinese drugs), and the production enterprise will set its own price according to the cost and market conditions within the range, and report to the regional price authorities for the record. 2, Shenzhen will cancel the second selection of drugs, broaden the basic drug configuration after the cancellation of drug addition last year, Shenzhen
06-12
Do you know the 6 taboos of medical device sales communication?
There must be art in communication and skill in speaking. If the sales in the conversation do not know the taboo, will cause failure; Not knowing what is appropriate creates stagnation. The author summed up the "six taboo" of sales consultant speaking from some sales failure cases for your reference.
Tuoxin medical equipment
Tel：0851-28837068
Tel：151 2024 3787
Email：964107559@qq.com
Address：7th floor, Guotou Building, Renmin Road, Huichuan District, Zunyi City, Guizhou Province
Qr code
©2023Guizhou Tuoxin medical equipment Co., LTD 300.cn guiyang Business license SEO